Roche's Bold $1 Billion Investment to Make Gene Therapies Affordable

In a groundbreaking move within the biotechnology sector, Roche has announced a remarkable investment of $1 billion aimed at making gene therapies more accessible and affordable. This high-stakes initiative comes in response to the widespread concern regarding the exorbitant costs associated with gene treatments, which have often barred patients from receiving potentially life-saving therapies.

Continue reading